A daunorubicin-blocked mutant strain RPM-5 derived from a new baumycin-producing Streptomyces sp. D788 accumulated a major precursor metabolite D788-1 (10-carboxy-13-deoxocarminomycin) and nine minor metabolites in the culture broth. Five among them were new with a substituent at C-10 or the altered side chains at C-9. Isolation, purification and identification of all anthracycline metabolites produced by strain RPM-5are described with their antitumor activities against L1210 cells.
A daunorubicin-blocked mutant strain RPM-5 derived from a new baumycin-producing Streptomyces sp. D788 accumulated a major precursor metabolite D788-1 (10-carboxy-13-deoxocarminomycin) and nine minor metabolites in the culture broth. Five among them were new with a substituent at C-10 or the altered side chains at C-9. Isolation, purification and identification of all anthracycline metabolites produced by strain RPM-5are described with their antitumor activities against L1210 cells.
Newanthracycline metabolites produced by biosynthetically blocked mutants are important sources in search for morepotent antitumor activity of anthracycline antibiotics and for the synthesis of anthracycline compoundswith improved antitumor efficacy. Isolation of a variety of blocked mutants is also indispensable to reveal a biosynthetic route in antibiotic production.
In preceding paper,1} we have reported the isolation of many blocked mutants from a baumycin (4'-substituted daunorubicin)-producing Streptomyces sp. D788. This paper deals with details of the anthracycline production by one of their blocked mutant, strain RPM-5. All detectable anthracycline metabolites accumulated in this culture broth were isolated, identified and quantified for their yields.
Ten anthracycline components were obtained including a major metabolite D788-1 (10-carboxy-13-deoxocarminomycin), which has been isolated as a water-soluble anthracycline from a daunorubicin beer.2) Eighty five %or more of a total yield of the anthracyclines was D788-1 and the remainder were shared by five new and four known minor components. Accordingly, it was proved that strain RPM-5 was a blocked mutant which resulted in a major accumulation of D788-1 by the genetic blockage in a biosynthetic step of 10-decarboxylation. All the anthracycline metabolites are also evaluated for their antitumor activities in vitro and in vivo on LI210 cells and discussed from a viewpoint of daunorubicin biosynthesis. The isolation of blocked mutant strain RPM-5was described in a preceding paper.1} The strain was grown on YS agar (yeast extract 0.3%, soluble starch 1.0% and agar 1.5%, pH 7.2) and stored at 5°C untiluse.
Fermentation and Extraction
The seed culture of strain RPM-5was grown using 500-ml Erlenmeyer flasks containing 100ml each of seed medium: Soybean meal 1%, glucose 0.5%, soluble starch 0.5%, yeast extract 0.1%, NaCl 0.1%, K2HPO40.1%, MgSO4-7H2O0.1% in tap water (pH 7.4 before autoclave). Cultivation was carried out at 30°C for 2 days on a rotary shaker (200rpm). Fermentation was then performed using a 30-liter jar containing 15 liters of a production medium.1* The seed culture (750ml) was added to the jar and 130-hour cultivation was done at 28°C with agitation at 450 rpm and aeration of 15 liters/minute to give a maximumyield. The fermentation broth was separated into supernatant fluid and mycelia by filtration after adjustment of pH to 1.7 with 6n H2SO4. The pigmented products were extracted from the mycelial cake with 80%acetone (pH 2.3). The extract was concentrated in vacuo and the aqueous concentrate was combined with the above filtrate. The resulting solution was adjusted to pH 2.3 with 4n NaOHand passed through a Diaion HP-20 column (750ml) at SV 4 to adsorb the pigments. After washing with water, the column was eluted with 50% acetone (pH 2.3, with HC1). The pigmented eluate was pooled and concentrated in vacuo. The concentrate was adjusted to pH 8.5 with 4n NaOH,and then extracted with CHC13. The CHC13layer was washed with water, dried over anhydrous Na2SO4and evaporated to a small volume. The crude anthracycline complex (1.18 g) was precipitated by addition of an excess of fl-hexane (extract A).
On the other hand, the aqueous layer after the CHC13extraction was adjusted to pH 2.5 with 6n HC1and extracted with rc-BuOH. The extract thus obtained was evaporated to dryness to yield 6.44g of crude anthracycline complex (extract B).
HPLC and TLC HPLCwas performed on a Hitachi 655 liquid chromatographic apparatus with a reverse phase analytical column, A312(ODS) (6 x 150mm) (Yamamura Chemical Laboratories Co., Ltd. Antitumor Activity In Vitro
Inhibitory effects on growth and nucleic acid synthesis in murine leukemia L1210 cell culture were determined according to the method as described previously.3) General MP's were determined on a Kofler hotstage microscope. UVspectra were determined on a Hitachi EPS 3T and IR spectra (KBr pellet) on a Hitachi EPI-GS spectrophotometer. *H and 13C NMRspectra were recorded with a Jeol GX-400spectrometer at 400 MHzand 100 MHz,respectively. Chemical shifts are expressed in S value (ppm) with TMSas an internal reference and coupling constants are given in J (Hz). Mass spectra were recorded with Hitachi M-80Hspectrometer. Specific rotations were determined on a Jasco DIP-181 Digital Polarimeter.
Results
Isolation and Purification HPLCanalysis revealed that crude extract A contained eight components: D788-2, D788-6, D788-7, D788-8, D788-9, D788-ll, D788-12 and D788-15, and crude extract B had three components: D788-1, D788-10 with concomitant D788-12. The D788-serial names have been used for anthracycline products obtained from the culture broths of Streptomyces sp. D788and its mutant isolates. but the others were partially purified. Further purification was carried out by alternate TLCusing two solvents. The TLCband containing each component completely separated was scraped off and eluted with CHC13-MeOH-H2O (40: 10: 1). Each eluate was evaporated to dryness. All components thus obtained, except for D788-1 and D788-10, were dissolved in 0.1 m AcOHbuffer (pH 3.0). After washed with CHCI3 and adjusted pH to 8.5 with 1 n NaOH, the solution was extracted with CHC13. The CHC13 layer was washed with saturated saline and dried over anhydrous Na2SO4and concentrated in vacuo. The addition of an excess of w-hexane gave all red powders. Whereas, D788-1 and D788-10 were dissolved in 1% NaHCO3and washed with CHC13. After pH adjustment to 2.5 with HC1, D788-1 solution were extracted with «-BuOHand D788-10 solution with CHC13. The solvent layers were evaporated to a small volumeand an excess of rc-hexane was added to precipitate pure compound. All the compounds, structurally elucidated as described below, are summarized in Fig. 2 .
Structural Determination In total acid hydrolysis (0.1 n HC1, 85°C, 30minutes) followed by TLCanalysis, all these compounds gave reddish aglycones and a sugar. The sugar was identified as daunosamine by comparing Rf value (0.25) and spot color (sky blue) on TLCwith authentic sample. The aglycones obtained from D788-6, D788-7 and D788-12 were £-rhodomycinone (e-RMN), jff-RMN and 13-dihydrocarminomycinone, respectively, by TLC comparison with the authentic samples, and by mass4) and *H and 13C NMR spectra.4~7) D788-1 and D788-10 were soluble in alkaline water and showed the presence of acidic group. lU NMRdata evidenced that D788-1, D788-2, D788-7, D788-ll and D788-12 were known compounds Table 1 . Their UVand Vis spectra in 90%MeOHsolution were similar to each other and the Amaxwere observed all around 235, 255 and 495nm. IR spectra (KBr) indicated that D788-6, D788-9 and D788-15 had an ester carbonyl (1720~1730cm"1) and D788-10 had a carbonyl group (1710cm"1). D788-8 had no peak at a similar wave length. Their *H and 13C NMRchemical shift assignments are shown in Tables 2 and 3, respectively. XH and 13C chemical shifts of D788-6, D788-15, D788-9 and D788-10 were almost identical to each other except for those of the substituents at C-9 and C-10. The 13C NMRchemical shifts of the aglycone Similar values may be interchanged. The value is obscure because of solvent interference. Determined by^-"C COSY. JAN. 1993 moiety of D788-6 were almost the same as those of e-RMNthough the chemical shift of C-7 shifted to a lower field because of the sugar linkage. The methoxycarbonyl signal at C-10 was also observed with D788-15 and D788-9. The methyl proton (3 1.4~1.5, singlet) which displayed long range connectivities to C-8, C-9 and C-10 was observed with D788-15 and D788-10. The chemical shifts of the side chain at C-9 of D788-9 were the same as those detected in sulfurmycins,11* indicating that C-9 was substituted with an acetonyl group. The carbonyl carbon of D788-10 was shifted to a lower field (3 173.89) as seen with D788-l,2) indicating the presence of a carboxyl group at C-10. Concerning D788-8, one additional proton (3 7.08, brd, 10-H) observed in an olefin field, and a lower-field chemical shift (3 4.49, q) of methine proton and a doublet signal at 3 1.42, correlated to the methine proton, showed that D788-8 was a 9,10-anhydroanthracycline as akrobomycin8) and the adjacent carbon to C-9 was oxidized to possess a hydroxyl group. The chemical shifts of sugar moieties of all these compounds agreed with those of daunosamine moiety in daunorubicin. The small coupling constants (/< 2.9 Hz) of all anomeric protons in these compoundsindicated the configurations of the glycosidic bonds were a. FAB-MSanalysis supported their molecular formula which were given by *H and 13C NMR analyses. These results proved new products to be 10-methoxycarbonyl-13-deoxocarminomycin (D788-6), 9, 10-anhydro-1 3-dihydrocarminomycin (D788-8), 10-methoxycarbonyl-4-O-demethylfeudomycin B (D788-9), 10-carboxy-4-O-demethylfeududomycin C (D788-10) and 10-methoxycarbonyl-4-O-demethylfeudomycin C (D788-15).
Antitumor Activity In Vitro Inhibitory activities of all anthracycline metabolites produced by strain RPM-5on the growth and nucleic acid synthesis of murine leukemia LI210 cell culture was examinedand the results are shownin Table 4 . As already reported, D788-7 had an intensely potent cell growth inhibitory activity and a high For the growth inhibition test, L1210 cell culture (5 x 104cells/ml) were exposed for 48 hours to the drugs and the viable cells were counted by Coulter counter. In the inhibition test for nucleic acid syntheses, L1210 cell cultures (8 x 105 cells/ml) with supplemented 14C-labeled uridine or thymidine (0.05 /iCi/ml) were exposed for 60 minutes to the drugs and the incorporation of the radioisotopes into acid insoluble material was measured. Details of the methodwas previously described. 3) IC50 values are expressed as drug concentration required to inhibit by 50% control of the growth. DNAand RNAof L1210 cell culture. Reference compound.
antitumor effect of about 200 (T/C %) against mice bearing LI210 cells under ip-ip treatment with daily ten doses (optimum dose: 0.06mg/kg).9) D788-1, D788-ll and D788-12 were as active as daunorubicin against L1210 cell culture. However, the activities of all the new compoundswere very weak and their antitumor effects in vivo were also less than 120 (T/C %) even in elevating dose more than lOmg/kg. Discussion A HPLCof direct acetone extract from RPM-5culture broth revealed only one major peak (corresponding to D788-1) and three minor peaks (corresponding to D788-6, D788-ll and D788-12). From their peak areas it was determined that about 95% of total anthracycline yields was D788-1 and the remaining 5% shared by the other components. This was also confirmed by a practical product isolation from 15-liter culture broth. A yield of D788-1 was about 2.5 g and total yields of the other nine components was about 0.45 g. These findings clearly show that strain RPM-5is a biosynthetic mutant which has a genetic blockage at a biosynthetic step of 10-decarboxylation from D788-1 to a 10-decarboxy precursor metabolite in daunorubicin production. The nine minor components were accumulated as either by-products (or degraded compounds) or precursor metabolites. D788-2 was a chemically degraded product from D788-1 with acetone and identified as akrobomycin.8) It seems that D788-7 (oxaunomycin),9) and D788-8 were also chemical by-products while D788-9, D788-10 and D788-15 were biosynthetic by-products. D788-6, D788-1 1 and D788-12 are some precursor metabolites in daunorubicin biosynthesis. We have isolated a blocked mutant 58NR-58 whose major product is D788-6.1) Details of this mutant will be described in the following paper.12) Weconsider that D788-6 is the precursor of D788-1 and D788-1 the precursor of D788-1 1 in the biosynthetic pathway of daunorubicin. Cassinelli et al. have reported that a mutant of daunorubicin-producing Streptomyces peucetius var caecius produces 13-deoxocarminomycin (D788-1 1). However, it is not shown whether it is a major or a minor product. Further evidence for the precursor activity of D788-1 1 would still need the isolation of a blocked mutant which accumulates it as a major product.
There were not biologically active compoundswith a good antitumor effect amongstrain RPM-5 products except for D788-7. The marked antitumor activity in vitro and in vivo of D788-7 has been previously clarified.9) The bioactivity of D788-1 was very interesting since it is the first anthracycline of acidic and water soluble property. However, it had only a little antitumor effect against L1210 cells although it exhibited a strong cell-growth inhibition activity comparative to that of daunorubicin.
However, it is a important chemical since it was found that a photochemical treatment of D788-1 was a very efficient way for D788-7 production.13)
